Daniel Faga, Chief Business Officer at Spark Therapeutics, Inc. (ONCE), sold 6,000 shares at $82.35 ($495K) on 2017-09-12, disclosed to the SEC on 2017-09-14.
Open-market sale of $495k ONCE by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.35 | 5,100 | $420K | 84.8% |
| 2 | $83.36 | 900 | $75K | 15.2% |
| Total | $82.50 avg | 6,000 | $495K | 100% |
| Filing → |
| ANAB | SELL | 2026-01-08 | $415K | — | Filing → |
| ANAB | SELL | 2026-01-06 | $662K | — | Filing → |
| ANAB | SELL | 2024-03-26 | $6.8M | — | Filing → |